Marcel Jabour Junqueira, MD | |
1600 N Grand Ave, Suite 140, Pueblo, CO 81003-2700 | |
(719) 564-1542 | |
(719) 566-0916 |
Full Name | Marcel Jabour Junqueira |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 22 Years |
Location | 1600 N Grand Ave, Pueblo, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831353705 | NPI | - | NPPES |
1831353705 | Other | CO | NPI |
40280748 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 50953 (Colorado) | Primary |
207RC0200X | Internal Medicine - Critical Care Medicine | 50953 (Colorado) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Parkview Medical Center, Inc | Pueblo, CO | Hospital |
San Luis Valley Health | Alamosa, CO | Hospital |
St Mary Corwin Med Ctr, Centura Health | Pueblo, CO | Hospital |
Rio Grande Hospital | Del norte, CO | Hospital |
San Luis Valley Health Conejos County Hospital | La jara, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Parkview Ancillary Services Corporation | 4385722511 | 267 |
Pueblo Pulmonary Associates | 2769372093 | 6 |
Pueblo Pulmonary Associates | 2769372093 | 6 |
News Archive
City children with asthma are more likely to have problems with behavior than children without the chronic respiratory problems, according to a University of Rochester Medical Center study in this month's Pediatrics.
Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression.
The DrySyn SnowStorm ONE from Asynt is designed to provide reliable temperature control of exothermic reactions.
Scientists at the University of Bonn and the Hebrew University of Jerusalem (Israel) have decoded a central signal cascade associated with epileptic seizures. If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased. Using a novel technology, it was possible to observe the processes prior to the occurrence of epileptic seizures in living animals.
StemCells, Inc. announced today that the United Kingdom (UK) Intellectual Property Office has granted patent number GB2451523 with broad claims covering true (germline competent) rat stem cells and genetically engineered rats derived from these cells. The patented technology is expected to have significant utility to academic and pharmaceutical industry researchers by enabling them to create novel rat models for the study of human diseases. Both mice and rats are used by scientists to model various human diseases.
› Verified 6 days ago
Entity Name | Pueblo Pulmonary Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760688444 PECOS PAC ID: 2769372093 Enrollment ID: O20040318001350 |
News Archive
City children with asthma are more likely to have problems with behavior than children without the chronic respiratory problems, according to a University of Rochester Medical Center study in this month's Pediatrics.
Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression.
The DrySyn SnowStorm ONE from Asynt is designed to provide reliable temperature control of exothermic reactions.
Scientists at the University of Bonn and the Hebrew University of Jerusalem (Israel) have decoded a central signal cascade associated with epileptic seizures. If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased. Using a novel technology, it was possible to observe the processes prior to the occurrence of epileptic seizures in living animals.
StemCells, Inc. announced today that the United Kingdom (UK) Intellectual Property Office has granted patent number GB2451523 with broad claims covering true (germline competent) rat stem cells and genetically engineered rats derived from these cells. The patented technology is expected to have significant utility to academic and pharmaceutical industry researchers by enabling them to create novel rat models for the study of human diseases. Both mice and rats are used by scientists to model various human diseases.
› Verified 6 days ago
Entity Name | Parkview Ancillary Services Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982878765 PECOS PAC ID: 4385722511 Enrollment ID: O20080429000248 |
News Archive
City children with asthma are more likely to have problems with behavior than children without the chronic respiratory problems, according to a University of Rochester Medical Center study in this month's Pediatrics.
Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression.
The DrySyn SnowStorm ONE from Asynt is designed to provide reliable temperature control of exothermic reactions.
Scientists at the University of Bonn and the Hebrew University of Jerusalem (Israel) have decoded a central signal cascade associated with epileptic seizures. If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased. Using a novel technology, it was possible to observe the processes prior to the occurrence of epileptic seizures in living animals.
StemCells, Inc. announced today that the United Kingdom (UK) Intellectual Property Office has granted patent number GB2451523 with broad claims covering true (germline competent) rat stem cells and genetically engineered rats derived from these cells. The patented technology is expected to have significant utility to academic and pharmaceutical industry researchers by enabling them to create novel rat models for the study of human diseases. Both mice and rats are used by scientists to model various human diseases.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Marcel Jabour Junqueira, MD 1600 N Grand Ave, Suite 140, Pueblo, CO 81003-2700 Ph: (719) 564-1542 | Marcel Jabour Junqueira, MD 1600 N Grand Ave, Suite 140, Pueblo, CO 81003-2700 Ph: (719) 564-1542 |
News Archive
City children with asthma are more likely to have problems with behavior than children without the chronic respiratory problems, according to a University of Rochester Medical Center study in this month's Pediatrics.
Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression.
The DrySyn SnowStorm ONE from Asynt is designed to provide reliable temperature control of exothermic reactions.
Scientists at the University of Bonn and the Hebrew University of Jerusalem (Israel) have decoded a central signal cascade associated with epileptic seizures. If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased. Using a novel technology, it was possible to observe the processes prior to the occurrence of epileptic seizures in living animals.
StemCells, Inc. announced today that the United Kingdom (UK) Intellectual Property Office has granted patent number GB2451523 with broad claims covering true (germline competent) rat stem cells and genetically engineered rats derived from these cells. The patented technology is expected to have significant utility to academic and pharmaceutical industry researchers by enabling them to create novel rat models for the study of human diseases. Both mice and rats are used by scientists to model various human diseases.
› Verified 6 days ago
Dr. Christopher John Calcagno, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 N. Grand Ave., Ste. 300, Pueblo, CO 81003 Phone: 719-562-2001 Fax: 719-562-2742 | |
Christopher Jon Stark, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-595-2218 Fax: 719-595-7994 | |
Greg Alan Bowman, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1600 N Grand Ave, Suite 500, Pueblo, CO 81003 Phone: 719-545-0663 Fax: 719-595-7903 | |
Lauren E. Sullenberger, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 902 Lakeview Ave, Pueblo, CO 81004 Phone: 719-557-5855 Fax: 719-557-5097 | |
Peter Lochow, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1593 | |
Dr. Raj Vashistha, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd., Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1592 | |
Dr. Rebecca Elizabeth Holder, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1207 Pueblo Boulevard Way, Pueblo, CO 81005 Phone: 719-542-0032 Fax: 719-553-1904 |